/Investor DB

Delta Capital — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

Adcentrx Therapeuticsadcentrx.cominApr 2023

Adcentrx Therapeutics is a biotech company focused on the discovery and clinical development of antibody-drug conjugates (ADCs) for oncology.

BiotechHealthtech

Hui Li(Founder, President & CEO)in

Co-investorsEight Roads VenturesF-Prime CapitalQuan Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.